Bio-Path Holdings, Inc.
At Close: 4:00 PM
Bio-Path Stock Price Graph
Bio-Path Stock Price Today
Bio-Path Holdings, Inc. (BPTH) stock rallied over 0.28% intraday to trade at $0.4613 a share on NASDAQ. The stock opened with a gain of 32.85% at $0.61 and touched an intraday high of $0.64, rising 0.28% against the last close of $0.46. The Bio-Path Holdings, Inc. in stock market went to a low of $0.61 during the session.
Bio-Path Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
Bio-Path Stock Price History Chart
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and prexigebersen-A for various solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.
Frequently Asked Questions
What is the current Bio-Path Holdings, Inc. (BPTH) stock price?
Bio-Path Holdings, Inc. (NASDAQ: BPTH) stock price is $0.46 in the last trading session. During the trading session, BPTH stock reached the peak price of $0.64 while $0.61 was the lowest point it dropped to. The percentage change in BPTH stock occurred in the recent session was 0.28% while the dollar amount for the price change in BPTH stock was $0.00.
BPTH's industry and sector of operation?
The NASDAQ listed BPTH is part of Biotechnology industry that operates in the broader Healthcare sector. Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States.
Who are the executives of BPTH?
Mr. Anthony Price
Senior Vice President of Fin., Accounting & Admin.
Mr. Peter H. Nielsen MBA
Co-Founder, Chairman, Chief Executive Officer, Pres, Chief Financial Officer & Treasurer
Dr. Ana Tari Ashizawa Ph.D., MBA
Senior Vice President of Research, Devel. & Clinical Design
Dr. Jeffery Lancet M.D.
How BPTH did perform over past 52-week?
BPTH's closing price is 0.17% higher than its 52-week low of $0.32 where as its distance from 52-week high of $3.3 is -0.69%.
How many employees does BPTH have?
Number of BPTH employees currently stands at N/A. BPTH operates from 4710 Bellaire Boulevard, Bellaire, TX 77401, US.
Link for BPTH official website?
Official Website of BPTH is: https://www.biopathholdings.com
How do I contact BPTH?
How many shares of BPTH are traded daily?
BPTH stock volume for the day was 57478.00 shares. The average number of BPTH shares traded daily for last 3 months was 2.69 Million.
What is the market cap of BPTH currently?
The market value of BPTH currently stands at $5.7 Million with its latest stock price at $0.46 and N/A of its shares outstanding.